Inhibition of dendritic cell maturation by herpes simplex virus

European Journal of Immunology

Volumn 29, Issue 10, 1999, Pages 3245-3253

  Salio, Mariolina ^a   Cella, Marina ^a   Suter, Mark ^b   Lanzavecchia, Antonio ^a  

^a BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Dendritic cell maturation; Herpes virus; Immunopathology; T lymphocyte stimulation

Indexed keywords

CYTOKINE; GREEN FLUORESCENT PROTEIN;

ARTICLE; BACTERIUM; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; LYMPHOID ORGAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS RECOMBINANT;

CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; HERPESVIRUS 1, HUMAN; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; RECEPTORS, VIRUS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032871905     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199910)29:10<3245::AID-IMMU3245>3.0.CO;2-X     Document Type: Article

References (42)

1. Hengel, H. and Koszinowski, U. H., Interference with antigen processing by viruses. Curr. Opin. lmmunol, 1997. 9: 470-476.
2. Wirtz, E. J., Mukherjee, S. and Ploegh, H. L, Viruses use stealth technology to escape from the host immune system. Mol. Med. Today 1997. 3: 116-123.
3. York, I. A., Roop, C., Andrews, D. W., Riddell, S. R., Graham, F. L. and Johnson, D. C., A cytosolic herpes simplex virus protein inhibits antigen presentation to CDS+ T lymphocytes. Cell 1994. 77: 525-535.
4. Hill, A., Jugovic, P., York, I., Russ, G., Bennink, J., Yewdell, J., Ploegh, H. and Johnson, D., Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995. 375: 411-415.
5. Fruh, K., Ahn, K., Djaballah, H., Sempe, P., van Endert, P. M., Tampe, R., Peterson, P. A. and Yang, Y., A viral inhibitor of peptide transporters for antigen presentation. Nature 1995. 375: 415-418.
6. Hsu, D. H., de Waal Matefyt, R., Florentine, D. F., Dang, M. N., Vieira, P., de Vries, J., Spits, H., Mosmann, T. R. and Moore, K. W., Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 1990. 250: 830-832.
7. Gooding, L. R., Virus proteins that counteract host immune defenses. Cell 1992. 71: 5-7.
8. Zou, P., Isegawa, Y., Nakano, K., Haque, M., Horiguchi, Y. and Yamanishi, K., Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J. Virol. 1999. 73: 5926-5933.
9. Isegawa, Y., Ping, Z., Nakano, K., Sugimoto, N. and Yamanish, K., Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol. 1998. 72: 6104-6112.
10. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
11. Sallusto, F. and Lanzavecchia, A., Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factors plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 1994. 179: 1109-1118.
12. Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I. and Lanzavecchia, A., Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999. 189: 821-829.
13. Montgomery, R. I., Warner, M. S., Lum, B. J. and Spear, P. G., Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 1996. 87: 427-436.
14. Geraghty, R. J., Krummenacher, C., Cohen, G. H., Eisenberg, R. J. and Spear, P. G., Entry of alphaherpes-viruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 1998. 280: 1618-1620.
15. Cocchi, F., Menotti, L., Mirandola, P., Lopez, M. and Campadelli-Fiume, G., The ectodomain of a novel member of the immunoglobulin subfamily related to the poliovirus receptor has the attributes of a bona fide receptor for hepres simplex virus types 1 and 2 in human cells. J. Virol. 1998. 72: 9992-10002.
16. Warner, M. S., Geraghty, R. J., Martinez, W. M., Montgomery, R. I., Whitbeck, J. C., Xu, R., Eisenberg, R. J., Cohen, G. H. and Spear, P. G., A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 1998. 246: 179-189.
17. Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N. and Minson, T., Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol. 1992. 66: 341-348.
18. McLean, C. S., Ni Challanain, D., Duncan, I., Boursnell, M. E., Jennings, R. and Inglis, S. C., Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine. Vaccine 1996. 14: 987-992.
19. Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Ait-Yahia, S., Briere, F., Zlotnik, A., Lebecque, S. and Caux, C., Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 1998. 188: 373-386.
20. Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Quin, S. and Lanzavecchia, A., Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. lmmunol. 1998. 28: 2760-2769.
21. Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T. and Nakano, H., Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 1999. 189: 451-460.
22. Grosjean, I., Caux, C., Bella, C., Berger, I., Wild, F., Banchereau, J. and Kaiserlian, D., Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J. Exp. Med. 1997. 186: 801-812.
23. Rogge, L., Barberis-Maino, L., Biffi, M., Passini, N., Presky, D. H., Gubler, U. and Sinigaglia, F., Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 1997. 185: 825-831.
24. Sydiskis, R. J. and Roizman, B., Polysemes and protein synthesis in cells infected with a DNA virus. Science 1966. 153: 76-78.
25. Kwong, A. D. and Frenkel, N., The herpes simplex virus virion host shutoff function. J. Virol. 1989. 63: 4834-4839.
26. Kwong, A. D., Kruper, J. A. and Frenkel, N., Herpes simplex virus virion host shutoff function. J. Virol. 1988. 62: 912-921.
27. Hayward, A. R., Read, G. S. and Cosyns, M., Herpes simplex virus interferes with monocyte accessory cell function. J. lmmunol. 1993. 150: 190-196.
28. Zachos, G., Clements, B. and Conner, J., Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J. Biol. Chem. 1999. 274: 5097-5103.
29. Qie, L, Marcellino, D. and Herold, B. C., Herpes simplex virus entry is associated with tyrosine phosphorylation of cellular proteins. Virology 1999. 256: 220-227.
30. McLean, C. S., Erturk, M., Jennings, R., Challanain, D. N., Minson, A. C., Duncan, I., Boursnell, M. E. and Inglis, S. C., Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J. Infect. Dis. 1994. 170: 1100-1109.
31. Boursnell, M. E., Entwisle, C., Blakeley, D., Roberts, C., Duncan, I. A., Chisholm, S. E., Martin, G. M., Jennings, R., Ni Challanain, D., Sobek, I., Inglis, S. C. and McLean, C. S., A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J. Infect. Dis. 1997. 175: 16-25.
32. Trinchieri, G., Aden, D. P. and Knowles, B. B., Cell-mediated cytotixicity to SV40-specific tumour-associated antigens. Nature 1976. 261: 312-314.
33. Bevan, M. J., Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross react in the cytotoxic assay. J. Exp. Med. 1976. 143: 1283-1288.
34. Albert, M. L., Sauter, B. and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998. 392: 86-89.
35. Sigal, L. J., Crotty, S., Andino, R. and Rock, K. L., Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen. Nature 1999. 398: 77-80.
36. Lane, P., Burdet, C., McConnell, F., Lanzavecchia, A. and Padovan, E., CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation. Eur. J. lmmunol. 1995. 25: 1788-1793.
37. Cella, M., Engering, A., Pinet, V., Pieters, J. and Lanzavecchia, A., Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997. 388: 782-787.
38. Lopez, M., Aoubala, M., Jordier, F., Isnardon, D., Gomez, S. and Dubreuil, P., The human poliovirus receptor related 2 protein is a new hematopietic/endothelial homophilic adhesion molecule. Blood 1998. 92: 4602-4611.
39. Cella, M., Scheidegger, D., Palmer Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
40. Farrell, H. E., McLean, C. S., Harley, C., Efstathiou, S., Inglis, S. and Minson, A. C., Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J. Virol. 1994. 68: 927-932.
41. McLean, C. S., Erturk, M., Jennings, R., Challanain, D. N., Minson, A. C., Duncan, I., Boursnell, M. E. and Inglis, S. C., Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1. J. Infect. Dis. 1994. 170: 1100-1109.
42. Cose, S. C., Jones, C. M., Wallace, M. E., Health, W. R. and Carbone, F. R., Anstigen-specific CDS+ T cell subset distribution in lymph nodes draining the site of herpes simplex virus infection. Eur. J. lmmunol. 1997. 27: 2310-2316.